Latest Breaking News On - Good clinical - Page 9 : comparemela.com

MRC/UVRI and LSHTM Uganda Research Unit unveils new facility to research infectious and non-communicable diseases

The facility commissioning ceremony was presided over by the Hon. Dr. Jane Ruth Aceng, the Minister of Health, and attended by Her Excellency Kate Airey OBE, the British High Commissioner to Uganda, and Professor Liam Smeeth, the Director of the London School of Hygiene & Tropical Medicine. Funded by Wellcome and the UKRI United Kingdom Research and Innovation/Medical Research Council, the solar-powered facility will be used to conduct clinical research in infectious and non-communicable diseases.

United kingdomJane ruth acengPontiano kaleebuGood clinical research practiceInnovation medical research councilLondon school of hygiene tropical medicineCommunity advisory boardsUnited kingdom researchLaboratory practiceMinistry of healthUganda research unitUganda virus research instituteHer excellency kate aireyBritish high commissionerProfessor liam smeethLondon school

Impact of previous exposure to SARS-CoV-2 and of S-Trimer (SCB-2019) COVID-19 vaccination on the risk of reinfection: a randomised, double-blinded, placebo-controlled, phase 2 and 3 trial

Impact of previous exposure to SARS-CoV-2 and of S-Trimer (SCB-2019) COVID-19 vaccination on the risk of reinfection: a randomised, double-blinded, placebo-controlled, phase 2 and 3 trial
thelancet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thelancet.com Daily Mail and Mail on Sunday newspapers.

District of columbiaUnited statesUnited kingdomLing chenSouth africaEteläuomen läiSouth koreaCity ofNoord hollandPilar rubioYung huangVincent mwangiKeith veitchCarole verhoevenHaijing qinStudy group

Safety and immunogenicity of two recombinant DNA COVID-19 vaccines containing the coding regions of the spike or spike and nucleocapsid proteins: an interim analysis of two open-label, non-randomised, phase 1 trials in healthy adults

Safety and immunogenicity of two recombinant DNA COVID-19 vaccines containing the coding regions of the spike or spike and nucleocapsid proteins: an interim analysis of two open-label, non-randomised, phase 1 trials in healthy adults
thelancet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thelancet.com Daily Mail and Mail on Sunday newspapers.

Soult ukpyolsiSouth koreaEteläuomen läiCh ungch ong buktoKyonggi doBionote hwaseong siKorea ministry of foodKorean ministry of foodNational culture collection for pathogenSeverance hospitalGangnam severanceGood clinicalKorea ministryDrug safetyInstitutional review boardSouth korean ministry

Determinants of suboptimal immune recovery among a Chinese Yi ethnicity population with sustained HIV suppression | BMC Infectious Diseases

Despite sustained viral suppression with effective antiretroviral therapy (ART), HIV-infected patients with suboptimal immune recovery are still at high risk of both non-AIDS-related and AIDS-related events. The aim of this study was to investigate determinants potentially associated with suboptimal CD4 + T cell count recovery during free ART with sustained viral suppression among an HIV-infected Yi ethnicity population in Liangshan Prefecture, an area in China with high HIV prevalence. This retrospective study included HIV-infected Yi adults (≥ 18 years and baseline CD4 + T cell count less than 500 cells/μL) for whom ART supported by National Free Antiretroviral Treatment Program was initiated between January 2015 and December 2018 in Zhaojue County, Liangshan Prefecture. Virological suppression (viral load < 50 copies/mL) was achieved within 12 months after ART initiation, and sustained virological suppress

New yorkUnited statesEteläuomen läiRoche cobas taqmanZhaojue countyLiangshan prefectureLiangshan yi autonomous prefectureSichuan provinceMedical ethics committeeWest china hospitalSichuan universityAnnual auditInternational conferenceHarmonization guidelinesGood clinical

Safety and immunogenicity of the SARS-CoV-2 ARCoV mRNA vaccine in Chinese adults: a randomised, double-blind, placebo-controlled, phase 1 trial

Safety and immunogenicity of the SARS-CoV-2 ARCoV mRNA vaccine in Chinese adults: a randomised, double-blind, placebo-controlled, phase 1 trial
thelancet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thelancet.com Daily Mail and Mail on Sunday newspapers.

Eteläuomen läiFuchun zhangAbogen biosciencesDongliang yang tongji medical collegePanyong mao department of infectious disease medicineInnovative research groupClinical trial ethics committee of shulan hangzhouChina national medical products administrationInnovation fund for medical sciencesNational science fund for distinguished young scholarDevelopment project of chinaNational medical products administration of chinaJielai xia air force medical universityHuazhong university of scienceTsinghua university spring breeze fundDrug administration